Professor Else Guthrie
Else is Professor of Psychological Medicine and an Honorary Consultant Psychiatrist at Leeds and York Partnership Foundation Trust. I was formerly based in Manchester, holding both academic positions at the University of Manchester and a clinical position in Liaison Psychiatry at Manchester Mental Health and Social Care Partnership. I ran the liaison psychiatry service at Manchester Royal Infirmary from 1994 to 2017. I was Senior Lecturer in Psychiatry at the University of Manchester from 1994-2001 and then Professor in Psychological Medicine from 2001 to 2004. I then became a full-time Consultant Psychiatry with an honorary chair at the University of Manchester from 2004 to 2017, when I took up my appointment in Leeds.
My main research interests include liaison psychiatry, psychological treatments and medically unexplained symptoms/long term conditions. I have completed several trials of psychological treatment for medically unexplained symptoms, and am particularly interested in researching a form of treatment called psychodynamic-interpersonal therapy or the conversational model of psychotherapy. I recently completed a programme grant which investigated the role of depression in long term conditions and the link to use of urgent care (Guthrie E, Afzal C, Blakeley C, Blakemore A, Byford R, et al. CHOICE: Choosing health options in chronic care emergencies. Southampton (UK): NIHR Journals Library; 2017 Jul. PMID:28767210).
Current research project include:
- Liaison Psychiatry: Measurement And Evaluation of Service Types, Referral patterns and Outcomes LP- MAESTRO Lead PI Professor A House .NIHR HS&DR project ref: 13/58/08 £1,246,989.80 2014-2017.
- Function REplacement in repeated Self-Harm: Standardising Therapeutic Assessment and the Related Therapy: FReSH START RP-PG-1016-20005- co-applicant £2,475,223.00-PfAR- This is a programme grant that leads to a definitive trial of psychological treatment (one of 3 therapies PIT, ACT or BA) for people with multiple self harm. 2018-2024;
- Low-dose antidepressants for the treatment of irritable bowel Syndrome £1,787,887.99 16/162 co-applicant HTA. RCT of amitriptyline for IBS in primary care. 2018-2022;
- Management of diarrhoea in patients with stable ulcerative colitis 17/33 £1,501,813.01 co-applicant HTA. RCT of a) diet b) antidepressant c) odansetron 2018-2022
- M.B. Ch.B.
Research groups and institutes
- Leeds Institute of Health Sciences